Insmed Stock Price Target Increased by TD Cowen

Wednesday, 29 May 2024, 11:51
The stock price target for Insmed has been raised to $67 by TD Cowen, signaling positive growth potential for the pharmaceutical company. This update comes following a detailed analysis of Insmed's performance and market trends. Investors can expect increased interest in Insmed stock as the revised price target indicates a bullish outlook for the company.
https://store.livarava.com/40b220d7-1dcb-11ef-a3e5-9d5fa15a64d8.jpg
Insmed Stock Price Target Increased by TD Cowen

Insmed PT Raised to $67 at TD Cowen

Insmed PT has been raised to $67 at TD Cowen, highlighting positive growth prospects. This update signifies a bullish sentiment towards the pharmaceutical company.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Related posts

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe